Former MedImmune Exec Pleads Guilty A former executive of the biotechnology company MedImmune faces from 15 to 21 months in prison after pleading guilty Friday to security fraud and perjury in US District Court in Washington. 

Which section of a newspaper would this article likely appear in? 